These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32222072)

  • 41. Proteomic profiling of aqueous humor-derived exosomes in Vogt-Koyanagi-Harada disease and Behcet's uveitis.
    Zhang Y; Deng Y; Jing S; Su G; Li N; Huang Z; Zhang W; Chen Z; Yang P
    Clin Immunol; 2024 Feb; 259():109895. PubMed ID: 38185270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. iPSC-based model of Vogt-Koyanagi-Harada disease for phenotype recapitulation and drug screening.
    Li W; Tan J; He S; Yue Y; Liu H; Li R; Wang X; Wang G; Fan W; Zhao C; Zhou Q; Yang P; Hou S
    Clin Immunol; 2023 Jan; 246():109205. PubMed ID: 36509389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease.
    Liang A; Jia S; Gao F; Han X; Pei M; Qu Y; Xiao J; Zhao C; Zhang M
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3395-3404. PubMed ID: 34216256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analyses of circRNA and mRNA Profiles in Vogt-Koyanagi-Harada Disease.
    Shu J; Su G; Zhang J; Liu Z; Chang R; Wang Q; Yang P
    Front Immunol; 2021; 12():738760. PubMed ID: 35003060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OR11H1 Missense Variant Confers the Susceptibility to Vogt-Koyanagi-Harada Disease by Mediating Gadd45g Expression.
    Li X; Wang G; Wang X; Li W; Li N; Liu X; Fan W; He S; Han Y; Su G; Cao Q; Yang P; Hou S
    Adv Sci (Weinh); 2024 Mar; 11(11):e2306563. PubMed ID: 38168905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of immune hub genes participating in the pathogenesis and progression of Vogt-Koyanagi-Harada disease.
    Wang Y; Ju Y; Wang J; Sun N; Tang Z; Gao H; Gu P; Ji J
    Front Immunol; 2022; 13():936707. PubMed ID: 35958546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
    Yang Y; Xiao X; Li F; Du L; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):1012-7. PubMed ID: 22247488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. JAK1, but not JAK2 and STAT3, confers susceptibility to Vogt-Koyanagi-Harada (VKH) syndrome in a Han Chinese population.
    Hu K; Hou S; Li F; Xiang Q; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3360-5. PubMed ID: 23611997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of ZC3HAV1 single nucleotide polymorphisms with the susceptibility of Vogt-Koyanagi-Harada Disease.
    Wu Q; Zhong Z; Zhou C; Cao Q; Su G; Yang P
    BMC Med Genomics; 2023 May; 16(1):113. PubMed ID: 37221558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders.
    Egbeto IA; Garelli CJ; Piedra-Mora C; Wong NB; David CN; Robinson NA; Richmond JM
    Front Immunol; 2020; 11():590558. PubMed ID: 33384688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors for Vogt-Koyanagi-Harada disease.
    Sheu SJ; Kou HK; Chen JF
    J Chin Med Assoc; 2003 Mar; 66(3):148-54. PubMed ID: 12779034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
    AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
    Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
    [No Abstract]   [Full Text] [Related]  

  • 53. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
    Li F; Yang P; Liu X; Wang C; Hou S; Kijlstra A
    Arch Ophthalmol; 2010 Nov; 128(11):1449-54. PubMed ID: 21060047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
    Yi X; Yang P; Sun M; Yang Y; Li F
    Mol Vis; 2011 Mar; 17():673-9. PubMed ID: 21403851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vogt-Koyanagi-Harada disease.
    Burkholder BM
    Curr Opin Ophthalmol; 2015 Nov; 26(6):506-11. PubMed ID: 26448042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease.
    Chang R; Yi S; Tan X; Huang Y; Wang Q; Su G; Zhou C; Cao Q; Yuan G; Kijlstra A; Yang P
    Br J Ophthalmol; 2018 Feb; 102(2):282-290. PubMed ID: 28972028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome.
    Golzarri MF; Cheja-Kalb R; Concha-Del-Río LE; Gonzalez-Salinas R; Arellanes-García L
    Ocul Immunol Inflamm; 2022 Feb; 30(2):265-269. PubMed ID: 33021860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
    Wang C; Tian Y; Lei B; Xiao X; Ye Z; Li F; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4668-75. PubMed ID: 22669715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
    Alvarez-Guzman C; Valdez-Garcia JE; Ruiz-Lozano RE; Rodriguez-Garcia A; Navas-Villar CF; Hartleben-Matkin C; Pedroza-Seres M
    Int Ophthalmol; 2022 Dec; 42(12):3913-3921. PubMed ID: 35789316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.
    Li K; Yang P; Zhao M; Hou S; Du L; Zhou H; Kijlstra A
    Mol Vis; 2009 May; 15():955-61. PubMed ID: 19452015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.